Skip to main content
. 2018 Oct 31;9:1–7. doi: 10.1016/j.tipsro.2018.10.001
GTV-Tinit Initial Gross Tumour Volume of the primary Tumour
CTV-T-HRinit Initial High Risk Clinical Target Volume of the primary Tumour
CTV-T-LRinit Initial Low Risk Clinical Target Volume of the primary Tumour
ITV-T-LRinit Initial Internal Target Volume of the primary Tumour
GTV-N Gross Tumour Volume of a individual pahtologic lymph Node
CTV-N Clinical Target Volume of a individual pahtologic lymph Node
PTV-N Planning Target Volume of a individual pahtologic lymph Node
CTV-E Clinical Target Volume of the elective nodal region, including pathological lymph nodes if present
ITV45 ITV-T-LR + CTV-E for 45 Gy
PTV45 Planning Target Volume for 45 Gy
GTVres Residual Gross Tumour Volume of the primary Tumour
CTVHR Adaptive Hight Risk Clinical Target Volume of the primary Tumour
CTVIR Intermediate Risk Clinical Target Volume of the primary Tumour